Bellevue Group AG
Q1 2024 13F-HR Holdings
Net value change ($000)
+19,396
(0.3%)
New positions
23
Sold out positions
15
Turnover %
3.9%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q4 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| DXCM | 55,888 | 49.2% |
| MGNX | 50,946 | 53.2% |
| COO | 40,317 | NEW |
| BSX | 32,360 | 17.7% |
| AGIO | 27,810 | 31.1% |
| EW | 27,717 | 35.7% |
| CLDX | 21,544 | 22.5% |
| SYK | 21,339 | 15.3% |
| BEAM | 20,508 | 108.4% |
| BDTX | 19,199 | 80.0% |
Top Reduces (Value $000, Stocks/ETFs)
| Axonics, Inc. | -114,078 | -100.0% |
| IONS | -81,057 | -18.4% |
| PACB | -54,560 | -76.0% |
| NBIX | -36,697 | -11.5% |
| COO | -32,560 | -100.0% |
| ALNY | -32,221 | -19.0% |
| EVH | -29,881 | -38.1% |
| Intra-Cellular Therapies, Inc. | -24,508 | -11.2% |
| APLS | -21,336 | -43.4% |
| VRTX | -20,086 | -6.7% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|